Amanat Acquisition to merge with Corxel Pharmaceuticals in deal with ~$300M PIPE

Amanat Acquisition Corp announced it will merge with Corxel Pharmaceuticals. The transaction includes a concurrent, oversubscribed PIPE with expected gross proceeds of roughly $300 million, in addition to about $75 million in Amanat's trust account.

Detected & updated continuously · Source: Nebula